Literature DB >> 26396621

Safe fronto-orbito-zygomatic osteotomy using a diamond-coated threadwire saw in orbito-zygomatic craniotomy.

Kojiro Wada1, Kentaro Mori1, Terushige Toyooka1, Naoki Otani1, Kazuya Fujii1, Hideaki Ueno1, Satoshi Tomura1, Arata Tomiyama1.   

Abstract

Orbito-zygomatic craniotomy is a widely accepted skull-based technique, but osteotomy at the malar eminence (ME) is complicated. We have developed a safe fronto-orbito-zygomatic (FOZ) osteotomy by creating small guide burr holes in the superior and lateral parts of the orbital wall and cutting the bone using a diamond-coated threadwire saw. This method involves standard two-piece osteotomy by creating small superior and lateral guide orbital burr holes instead of sectioning into the superior and inferior orbital fissures. The guide burr holes are connected using a diamond-coated threadwire saw to create the FOZ bar. This method was applied to the treatment of four patients with skull-based tumors or internal carotid and basilar artery aneurysms. Postoperative three-dimensional bone density computed tomography showed minimum bone gap in the ME. No craniotomy-related complication has occurred. FOZ osteotomy by creating guide burr holes in the orbital wall and cutting the bone using a diamond-coated threadwire saw is safe and results in minimum bone gap in the ME.

Entities:  

Keywords:  Diamond-coated threadwire saw; orbital guide burr holes; orbito-zygomatic approach; skull-based surgery

Year:  2015        PMID: 26396621      PMCID: PMC4553746          DOI: 10.4103/1793-5482.161190

Source DB:  PubMed          Journal:  Asian J Neurosurg


  10 in total

1.  Repositioning of Cranial Bone Flaps Cut with a Diamond-Coated Threadwire Saw: 5-Year Experience with Cosmetic Cranioplasty without Fixation Devices.

Authors:  Satoru Shimizu; Koji Kondo; Tomoya Yamazaki; Kenji Nakayama; Isao Yamamoto; Kiyotaka Fujii
Journal:  Skull Base       Date:  2011-09

2.  Development of artificial cranial base model with soft tissues for practical education: technical note.

Authors:  Kentaro Mori; Takuji Yamamoto; Yasuaki Nakao; Takanori Esaki
Journal:  Neurosurgery       Date:  2010-06       Impact factor: 4.654

3.  One-piece versus two-piece orbitozygomatic craniotomy: quantitative and qualitative considerations.

Authors:  Necmettin Tanriover; Arthur J Ulm; Albert L Rhoton; Masatou Kawashima; Nobutaka Yoshioka; Stephen B Lewis
Journal:  Neurosurgery       Date:  2006-04       Impact factor: 4.654

4.  Supratentorial craniotomy using a threadwire saw. Technical note.

Authors:  Satoru Shimizu; Tomoko Miyazaki; Sachio Suzuki; Masaru Yamada; Satoshi Utsuki; Hidehiro Oka; Kiyotaka Fujii
Journal:  Neurol Med Chir (Tokyo)       Date:  2008-04       Impact factor: 1.742

5.  Orbitozygomatic craniotomy. Technical note.

Authors:  J M Zabramski; T Kiriş; S K Sankhla; J Cabiol; R F Spetzler
Journal:  J Neurosurg       Date:  1998-08       Impact factor: 5.115

6.  Three-piece orbitozygomatic approach.

Authors:  Alvaro Campero; Carolina Martins; Mariano Socolovsky; Rafael Torino; Alexandre Yasuda; Luis Domitrovic; Albert Rhoton
Journal:  Neurosurgery       Date:  2010-03       Impact factor: 4.654

7.  The threadwire saw: a new device for cutting bone.

Authors:  K Tomita; N Kawahara
Journal:  J Bone Joint Surg Am       Date:  1996-12       Impact factor: 5.284

8.  Expansive midline T-saw laminoplasty (modified spinous process-splitting) for the management of cervical myelopathy.

Authors:  K Tomita; N Kawahara; Y Toribatake; J G Heller
Journal:  Spine (Phila Pa 1976)       Date:  1998-01-01       Impact factor: 3.468

9.  The orbitozygomatic infratemporal approach: a new surgical technique.

Authors:  A Hakuba; S Liu; S Nishimura
Journal:  Surg Neurol       Date:  1986-09

10.  One-piece pedunculated frontotemporal orbitozygomatic craniotomy by creation of a subperiosteal tunnel beneath the temporal muscle: technical note.

Authors:  Nakamasa Hayashi; Yutaka Hirashima; Masanori Kurimoto; Takashi Asahi; Takahiro Tomita; Shunro Endo
Journal:  Neurosurgery       Date:  2002-12       Impact factor: 4.654

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.